Cargando…

Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer

IMPORTANCE: Racial and ethnic disparities in prostate cancer are poorly understood. A given disparity-related factor may affect outcomes differently at each point along the highly variable trajectory of the disease. OBJECTIVE: To examine clinical outcomes by race and ethnicity in patients with nonme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Kelli M., Patil, Vikas, Li, Chunyang, Yong, Christina, Appukkutan, Sreevalsa, Grossman, Jamie Partridge, Jhaveri, Jay, Halwani, Ahmad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568364/ https://www.ncbi.nlm.nih.gov/pubmed/37819658 http://dx.doi.org/10.1001/jamanetworkopen.2023.37272

Ejemplares similares

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer
por: Appukkuttan, Sreevalsa, et al.
Publicado: (2021)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer
por: Feng, Felix Y., et al.
Publicado: (2021)

Disparities in Wait Times for Care Among US Veterans by Race and Ethnicity
por: Gurewich, Deborah, et al.
Publicado: (2023)

Nonmetastatic Castration-Resistant Prostate Cancer
por: Hong, Jun Hyuk, et al.
Publicado: (2014)

Analysis by Gender and Race and Ethnicity of Reviewers and Awardees for Intramural Research Funding in the Veterans Health Administration
por: Boyer, Taylor L., et al.
Publicado: (2023)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Predicting Survival in Veterans with Follicular Lymphoma Using Structured Electronic Health Record Information and Machine Learning
por: Li, Chunyang, et al.
Publicado: (2021)

Neighborhood Disadvantage, Race and Ethnicity, and Postpartum Depression
por: Onyewuenyi, Ticara L., et al.
Publicado: (2023)

Treatment Patterns and Outcomes in a Nationwide Cohort of Older and Younger Veterans with Waldenström Macroglobulinemia, 2006–2019
por: Chien, Hsu-Chih, et al.
Publicado: (2021)

Integration of Patient-Reported Outcome Measures in the Electronic Health Record: The Veterans Affairs Experience
por: Friedman, Daphne R., et al.
Publicado: (2022)

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022)

Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
por: Schultz, Neil M., et al.
Publicado: (2020)

Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
por: Essien, Utibe R., et al.
Publicado: (2021)

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
por: Rhea, Logan P, et al.
Publicado: (2019)

Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022)

Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2023)

Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020)

Denosumab: Delay of bone metastasis in men with nonmetastatic castrate-resistant prostate cancer
por: Manger, Jules P., et al.
Publicado: (2012)

Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
por: López-Campos, Fernando, et al.
Publicado: (2021)

Inclusion of Race and Ethnicity With Neighborhood Socioeconomic Deprivation When Assessing COVID-19 Hospitalization Risk Among California Veterans Health Administration Users
por: Wong, Michelle S., et al.
Publicado: (2023)

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer
por: Ogita, Shin, et al.
Publicado: (2012)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019)

Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021)

Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
por: Yokomizo, Akira, et al.
Publicado: (2021)

Race/Ethnicity and Geographic Access to Urban Trauma Care
por: Tung, Elizabeth L., et al.
Publicado: (2019)

Race and Ethnicity and Primary Language in Emergency Department Triage
por: Joseph, Joshua W., et al.
Publicado: (2023)

Human Papillomavirus Awareness by Educational Level and by Race and Ethnicity
por: Stephens, Erica S., et al.
Publicado: (2023)

Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System
por: Yamoah, Kosj, et al.
Publicado: (2022)

Racial and Ethnic Variation in Complementary and Integrative Health Therapy Use Among US Veterans
por: Tobin, Jessica, et al.
Publicado: (2023)

Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer
por: Hakozaki, Yuji, et al.
Publicado: (2022)

Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
por: Yokomizo, Akira, et al.
Publicado: (2022)

Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors
por: Saad, Fred, et al.
Publicado: (2021)

Ethnicity and Race Variations in Receipt of Surgery among Veterans with and without Depression
por: Copeland, Laurel A., et al.
Publicado: (2011)

Eligibility for Human Leukocyte Antigen–Based Therapeutics by Race and Ethnicity
por: Olivier, Timothée, et al.
Publicado: (2023)

Race and Ethnicity and Emergency Department Discharge Against Medical Advice
por: Tsai, Jennifer W., et al.
Publicado: (2023)

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020)

Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19
por: Castro, Alexander D., et al.
Publicado: (2022)

Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival
por: Chao, Joseph, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_meg3rj9u8llmj8b5aaijhto583